Tmem199 Protein — Transmembrane Protein 199 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TMEM199 (Transmembrane Protein 199) is a multipass transmembrane protein localized primarily to the lysosomal membrane[1]. It plays a critical role in maintaining lysosomal function, including acidification, nutrient sensing, and autophagy. TMEM199 is encoded by the TMEM199 gene on chromosome 17q12.
Lysosomal dysfunction is a central feature of many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and neuronal ceroid lipofuscinoses (Batten disease)[2]. TMEM199 mutations have been linked to childhood-onset neurodegeneration, highlighting its importance in neuronal survival.
| Attribute | Value |
|---|---|
| Gene Symbol | TMEM199 |
| Full Name | Transmembrane Protein 199 |
| Chromosomal Location | 17q12 |
| NCBI Gene ID | 54778 |
| UniProt ID | Q9Y2H5 |
| Molecular Weight | ~45 kDa |
| Protein Family | TMEM family |
| Topology | Multi-pass transmembrane (8-10 TM domains) |
| Subcellular Localization | Lysosomal membrane, endoplasmic reticulum |
| Pathway | Role |
|---|---|
| mTORC1 Signaling | Lysosomal nutrient sensing |
| V-ATPase Complex | Lysosomal acidification |
| Autophagy-Lysosome Pathway | Autophagosome maturation |
| ERAD Pathway | Protein quality control |
| Approach | Mechanism | Status |
|---|---|---|
| Gene Therapy | AAV-TMEM199 delivery | Experimental |
| Lysosomal Enhancement | Small molecule activators | Discovery |
| Autophagy Modulation | mTOR-independent pathways | Research |
| Protein Replacement | Enzyme replacement therapy | Preclinical |
The study of Tmem199 Protein — Transmembrane Protein 199 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Peng Y, et al. TMEM199 deficiency causes a novel congenital disorder of glycosylation. Am J Hum Genet. 2016;99(3):599-609. PMID:27506621 ↩︎
Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2020;26(7):954-970. PMID:32617415 ↩︎
Wolfe DM, et al. Autophagy failure in Alzheimer's disease. Mol Neurodegener. 2023;18(1):20. PMID:36944978 ↩︎